This company named MannKind came into my attention after the drop of it's price of 45.86% today. I was doing a research on why this company ended up in such fate. Then I learn about their product...
Holy c***! Inhalable insulin!? Why i never heard of such thing before?!
My dad had type 2 diabetes for over 20 years. He just switched to Sanofi pen recently (from taking Acarbose). Since he is old, he got a lot of trouble when he start using the pen. Now, it came into my worry when I plan for his trip to oversea (flight). Although there should be very little concern about carrying the pen throught the airport.
Look, nobody likes to poke something into their own skin! If I know there's such thing as Insulin Inhaler, I would use it instead of the injection pen! Seriously! The disposal of the needle is troublesome, and I always need to make sure my mom didn't get hurt when disposing it.
Therefore, this product called Afrezza, which is an insulin inhaler, strike my attention. When I read the earning data of MannKind, I was shocked. How could it be? There are so many diabetes patients in this world and insulin is the best medicine known! The only obstacle for the diabetes patients to access insulin is becasue it involves injection. Such product suppose to shake the world and it is totally revoluntionary for the diabetes patients!
The problem is, how could this product did badly in their sales?
Wrong Partner
Mannkind had clearly selected the wrong partner. Of course Sanofi is the giant in diabetes medicine industry. However, if I'm Sanofi, I would just take the partnership deal, and kill the product silently until the day when the patents expire. Why? Because it will kill the sales of the pen, the needles which is the main prodcut held by Sanofi! To make things short, I won't help my potential competitor. It's either you offer me super cheap price to take up your patent, or you'll face the challenge! This is how the giant pharmaceutical company survive! Get real, MannKind!
Very Little Marketing
Is this Afrezza a new product? Nope. And there are people never heard of it! When I google about it, there's only a few youtube videos review about it. It doesn't seem like a proper marketing. May be MannKind is a small company, that it doesn't have the capability to market a product like how Pfizer, GSK, Sanofi does.
If I am the CEO
MARKETING! That's the key! Get all out! Make everyone aware of it! It's clear that the existing CEO is trying to make an easy way out by partnership with Sanofi. Well, there's no easy business in this world! And because of the recent termination of that contract with Sanofi, it might mark a correct path for MannKind, but the future might be tough for MannKind.
I wish I can get the Afrezza inhaler for my dad if it available in my country. I bet every diabetes patients want this product too! Therefore, MannKind, please survive for the goodness of mankind!
Disclaimer: I have bought 100 unit of MNKD for the support of their product. This is a high risk investment which I might not get back any of my investment if the company gets delisted. However, I do have a strong hope that this product to be available around the world to benefits all the diabetes patients. I call it a non-profit investment. It would be a blessing if it does profitable in the future,
No comments:
Post a Comment